동물용 구충제 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of animal parasiticides Market

The global animal parasiticides market size was valued at USD 12.96 billion in 2025 and is projected to grow from USD 13.82 billion in 2026 to USD 23.73 billion by 2034, registering a CAGR of 6.99% from 2026 to 2034. North America dominated the global market with a 30.48% share in 2025, supported by rising pet ownership, demand for animal protein, awareness of animal health, and strong product offerings from leading companies.

Animal parasiticides are products used to prevent, treat, and control parasitic infestations in animals. They address external parasites such as ticks, fleas, and mites, as well as internal parasites including worms and protozoa. Increasing parasite infections among companion and livestock animals, together with growing veterinary care and preventive treatment, is supporting market expansion.

Market Definition and Scope

The animal parasiticides market covers products used across companion animals and livestock. The market is segmented by product, animal type, route of administration, and distribution channel. Major product categories include ectoparasiticides, endoparasiticides, and endectocides, while distribution channels include veterinary clinics, pharmacies and drug stores, veterinary hospitals, and others.

Market Dynamics

Market Drivers

Increasing demand for animal protein is a major factor driving the market. Livestock producers are increasingly adopting parasite-control solutions to maintain animal health, productivity, and disease prevention. The FAO has estimated continued growth in animal protein production, supporting demand for effective parasite management.

Growing pet ownership is another important driver. Parasite infections can cause skin irritation, hair loss, bites, and other health problems, encouraging pet owners to adopt preventive treatments. The presence of major companies such as Zoetis, Elanco, and Virbac is also supporting product availability and innovation.

Market Restraints

Anti-parasiticide resistance is a significant restraint. Excessive or inappropriate use of these products can contribute to genetic adaptations in parasites, making infections more difficult to control. In March 2025, NOAH launched the "Use It Right, Treat Them Right" campaign to promote responsible use of anti-parasitic medicines.

Market Opportunities

The expansion of the companion animal sector is creating significant opportunities. Rising pet ownership and the humanization of pets are increasing demand for preventive parasite-control products. Growing awareness of zoonotic diseases is also encouraging pet owners to maintain regular parasite prevention programs.

Market Challenges

Counterfeit and substandard parasiticides can negatively affect consumer trust and brand reputation. Similar packaging may cause confusion, while ineffective or harmful products can reduce confidence in genuine treatments. In June 2025, U.K. authorities warned about toxic insecticides found in counterfeit flea treatments that caused severe poisoning in cats.

Market Trends

Increasing research and development investment is a key trend. Parasite resistance is encouraging companies and biotechnology firms to develop new therapies and alternative mechanisms of action. In July 2025, ASTRA Therapeutics secured USD 8.9 million in seed funding for drug development targeting eukaryotic pathogens and parasite-related threats.

Segmentation Analysis

By Product

Endoparasiticides held the largest market share in 2025, supported by the prevalence of internal parasites and new product launches. In July 2023, Boehringer Ingelheim received U.S. FDA approval for NexGard Plus, designed to provide protection against internal and external parasites.

By Animal Type

The companion animal segment dominated with a 52.9% share in 2025, supported by increasing pet ownership and greater focus on pet healthcare. The livestock segment is projected to grow at a CAGR of 6.05%.

By Route of Administration

The oral segment held the leading position, supported by ease of administration and product availability. The parenteral segment is projected to grow at a CAGR of 6.42%.

By Distribution Channel

Pharmacies and drug stores dominated with a 36.4% share in 2025, benefiting from accessibility and availability of generic products. Veterinary clinics are projected to grow at a CAGR of 7.44%.

Regional Insights

North America was valued at USD 3.95 billion in 2025 and reached USD 4.19 billion in 2026. The U.S. accounted for USD 3.73 billion in 2025, supported by pet ownership, livestock production, and advanced animal healthcare.

Europe reached USD 3.52 billion in 2025 and is projected to grow at a CAGR of 6.24%. The U.K., Germany, and France recorded USD 1.09 billion, USD 0.49 billion, and USD 0.58 billion, respectively.

Asia Pacific reached USD 3.08 billion in 2025, with China at USD 1.12 billion and India at USD 0.45 billion. Latin America reached USD 1.34 billion, while GCC markets in the Middle East & Africa reached USD 0.55 billion.

Competitive Landscape

Key companies include Zoetis Services LLC, Merck & Co., Elanco, Boehringer Ingelheim, Ceva, Vetoquinol, Dechra Pharmaceuticals, and Virbac. Companies are focusing on product launches, regulatory approvals, research, strategic partnerships, and innovative parasite-control solutions.

Recent developments include Zoetis receiving a new Simparica Trio indication in April 2025 and Merck presenting its BRAVECTO fluralaner portfolio in August 2025.

Report Coverage

The report covers market size, market value, growth trends, product categories, animal types, administration routes, distribution channels, regional markets, competitive developments, and key industry strategies influencing the animal parasiticides industry.

Conclusion

The global animal parasiticides market is projected to increase from USD 12.96 billion in 2025 to USD 13.82 billion in 2026 and USD 23.73 billion by 2034, at a CAGR of 6.99% from 2026 to 2034. Rising animal protein demand, increasing pet ownership, growing awareness of preventive veterinary care, and continued product innovation are supporting market expansion. At the same time, parasite resistance, counterfeit products, and limited access to advanced animal healthcare remain important challenges for industry participants.

Segmentation Pruodct, Animal Type, Route of Administration, Distribution Channel, and Region

By Product

• Ectoparasiticides
• Endoparasiticides
• Endectocides

By Animal Type Companion

• Feline
• Canine
• Avian
• Others

Livestock

• Poultry
• Porcine
• Bovine
• Others

By Route of Administration

• Oral
• Parenteral
• Topical
• Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others

By Region North America (By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)

• U.S.
• Canada

Europe (By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)

• U.K.
• Germany
• France
• Italy
• Spain
• Scandinavia
• Rest of Europe

Asia Pacific (By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)

• Japan
• China
• India
• Australia
• Southeast Asia
• Rest of Asia Pacific

Latin America (By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa (By Product, By Animal Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)

• GCC
• South Africa
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview of Animal Diseases by Key Countries, By Key Countries/ Region, 2025
• 4.2. Pipeline Analysis
• 4.3. Regulatory Scenario By Key Countries/ Region, 2025
• 4.4. Pricing Analysis
• 4.5. Pet Ownership Statistics, By Key Countries/ Region, 2025
• 4.6. Snapshot on the Novel & Upcoming Therapies
• 4.7. Overview of Treatment Plans for Different Animal Diseases
• 4.8. New Product Launches, By Key Players
• 4.9. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.10. Impact of COVID-19 on the Global Animal Parasiticides Market

5. Global Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Ectoparasiticides
  • 5.1.2. Endoparasiticides
  • 5.1.3. Endectocides
• 5.2. Market Analysis, Insights and Forecast - By Animal Type
  • 5.2.1. Companion
    • 5.2.1.1. Feline
    • 5.2.1.2. Canine
    • 5.2.1.3. Avian
    • 5.2.1.4. Others
  • 5.2.2. Livestock
    • 5.2.2.1. Poultry
    • 5.2.2.2. Porcine
    • 5.2.2.3. Bovine
    • 5.2.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 5.3.1. Oral
  • 5.3.2. Parenteral
  • 5.3.3. Topical
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.4.1. Veterinary Hospitals
  • 5.4.2. Veterinary Clinics
  • 5.4.3. Pharmacies & Drug Stores
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Ectoparasiticides
  • 6.1.2. Endoparasiticides
  • 6.1.3. Endectocides
• 6.2. Market Analysis, Insights and Forecast - By Animal Type
  • 6.2.1. Companion
    • 6.2.1.1. Feline
    • 6.2.1.2. Canine
    • 6.2.1.3. Avian
    • 6.2.1.4. Others
  • 6.2.2. Livestock
    • 6.2.2.1. Poultry
    • 6.2.2.2. Porcine
    • 6.2.2.3. Bovine
    • 6.2.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 6.3.1. Oral
  • 6.3.2. Parenteral
  • 6.3.3. Topical
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.4.1. Veterinary Hospitals
  • 6.4.2. Veterinary Clinics
  • 6.4.3. Pharmacies & Drug Stores
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Ectoparasiticides
  • 7.1.2. Endoparasiticides
  • 7.1.3. Endectocides
• 7.2. Market Analysis, Insights and Forecast - By Animal Type
  • 7.2.1. Companion
    • 7.2.1.1. Feline
    • 7.2.1.2. Canine
    • 7.2.1.3. Avian
    • 7.2.1.4. Others
  • 7.2.2. Livestock
    • 7.2.2.1. Poultry
    • 7.2.2.2. Porcine
    • 7.2.2.3. Bovine
    • 7.2.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 7.3.1. Oral
  • 7.3.2. Parenteral
  • 7.3.3. Topical
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.4.1. Veterinary Hospitals
  • 7.4.2. Veterinary Clinics
  • 7.4.3. Pharmacies & Drug Stores
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. Germany
  • 7.5.2. U.K.
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Ectoparasiticides
  • 8.1.2. Endoparasiticides
  • 8.1.3. Endectocides
• 8.2. Market Analysis, Insights and Forecast - By Animal Type
  • 8.2.1. Companion
    • 8.2.1.1. Feline
    • 8.2.1.2. Canine
    • 8.2.1.3. Avian
    • 8.2.1.4. Others
  • 8.2.2. Livestock
    • 8.2.2.1. Poultry
    • 8.2.2.2. Porcine
    • 8.2.2.3. Bovine
    • 8.2.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 8.3.1. Oral
  • 8.3.2. Parenteral
  • 8.3.3. Topical
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.4.1. Veterinary Hospitals
  • 8.4.2. Veterinary Clinics
  • 8.4.3. Pharmacies & Drug Stores
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. China
  • 8.5.2. Japan
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Ectoparasiticides
  • 9.1.2. Endoparasiticides
  • 9.1.3. Endectocides
• 9.2. Market Analysis, Insights and Forecast - By Animal Type
  • 9.2.1. Companion
    • 9.2.1.1. Feline
    • 9.2.1.2. Canine
    • 9.2.1.3. Avian
    • 9.2.1.4. Others
  • 9.2.2. Livestock
    • 9.2.2.1. Poultry
    • 9.2.2.2. Porcine
    • 9.2.2.3. Bovine
    • 9.2.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 9.3.1. Oral
  • 9.3.2. Parenteral
  • 9.3.3. Topical
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.4.1. Veterinary Hospitals
  • 9.4.2. Veterinary Clinics
  • 9.4.3. Pharmacies & Drug Stores
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Animal Parasiticides Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Ectoparasiticides
  • 10.1.2. Endoparasiticides
  • 10.1.3. Endectocides
• 10.2. Market Analysis, Insights and Forecast - By Animal Type
  • 10.2.1. Companion
    • 10.2.1.1. Feline
    • 10.2.1.2. Canine
    • 10.2.1.3. Avian
    • 10.2.1.4. Others
  • 10.2.2. Livestock
    • 10.2.2.1. Poultry
    • 10.2.2.2. Porcine
    • 10.2.2.3. Bovine
    • 10.2.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Route of Administration
  • 10.3.1. Oral
  • 10.3.2. Parenteral
  • 10.3.3. Topical
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.4.1. Veterinary Hospitals
  • 10.4.2. Veterinary Clinics
  • 10.4.3. Pharmacies & Drug Stores
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Zoetis Services LLC
  • 11.2.2. Merck & Co., Inc.
  • 11.2.3. Elanco
  • 11.2.4. Boehringer Ingelheim International GmbH
  • 11.2.5. Ceva
  • 11.2.6. Vetoquinol
  • 11.2.7. Dechra Pharmaceuticals Limited
  • 11.2.8. Virbac Corporation